Reducing barriers to mainstream gene therapy 07-Sep-2020 By Jane Byrne AskBio, which develops adeno-associated virus (AAV) gene therapies for genetic disorders, has won an R&D grant valued at £2m (around US$2.7m) from Scottish Enterprise.